OMNIA-2: Phase I/II study of ANV419, an IL-2R-bg targeted antibody-IL-2 fusion protein, in patients with relapsed or refractory multiple myeloma.
ANV-419
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: OMNIA-2: Phase I/II study of ANV419, an IL-2R-bg targeted antibody-IL-2 fusion protein, in patients with relapsed or refractory multiple myeloma. ### Output: ANV-419